• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌和卵巢癌易感性的基因检测:一段家族经历

Genetic testing for breast and ovarian cancer susceptibility: a family experience.

作者信息

Van Riper Marcia, McKinnon Wendy C

机构信息

School of Nursing, Carolina Center for Genome Sciences, University of North Carolina at Chapel Hill, Carrington Hall CB #7460, Chapel Hill, NC 27599, USA.

出版信息

J Midwifery Womens Health. 2004 May-Jun;49(3):210-9. doi: 10.1016/j.jmwh.2004.01.021.

DOI:10.1016/j.jmwh.2004.01.021
PMID:15134674
Abstract

The purpose of this article is to provide an overview of current knowledge concerning genetic testing for breast and ovarian cancer susceptibility. This overview includes 1) a brief history of genetic testing for breast and ovarian cancer susceptibility, 2) a review of factors that midwives and other health care providers need to consider before offering this type of testing to their clients, 3) management options for clients at high risk for hereditary breast and ovarian cancers, and 4) a discussion of preliminary findings from an ongoing study concerning the family experience of genetic testing, which illustrates some of the ethical issues that emerge for individuals and families during the family experience of genetic testing for breast and ovarian cancer susceptibility.

摘要

本文旨在概述目前关于乳腺癌和卵巢癌易感性基因检测的知识。该概述包括:1)乳腺癌和卵巢癌易感性基因检测的简史;2)助产士和其他医疗服务提供者在为客户提供此类检测之前需要考虑的因素回顾;3)遗传性乳腺癌和卵巢癌高危客户的管理选择;4)一项正在进行的关于基因检测家庭体验的研究的初步结果讨论,该研究说明了在乳腺癌和卵巢癌易感性基因检测的家庭体验过程中,个人和家庭出现的一些伦理问题。

相似文献

1
Genetic testing for breast and ovarian cancer susceptibility: a family experience.乳腺癌和卵巢癌易感性的基因检测:一段家族经历
J Midwifery Womens Health. 2004 May-Jun;49(3):210-9. doi: 10.1016/j.jmwh.2004.01.021.
2
Genetic testing and the family.基因检测与家庭
J Midwifery Womens Health. 2005 May-Jun;50(3):227-33. doi: 10.1016/j.jmwh.2005.02.008.
3
Genetic susceptibility to breast and ovarian cancer: risk assessment, genetic counseling, and management issues.乳腺癌和卵巢癌的遗传易感性:风险评估、遗传咨询及管理问题。
Mo Med. 2004 Mar-Apr;101(2):105-10; quiz 110-1.
4
Psychological impact of genetic testing for cancer susceptibility: an update of the literature.癌症易感性基因检测的心理影响:文献综述更新
Psychooncology. 2005 Dec;14(12):1060-74. doi: 10.1002/pon.933.
5
Genetic testing for hereditary breast and ovarian cancer: responsibility and choice.遗传性乳腺癌和卵巢癌的基因检测:责任与选择
Qual Health Res. 2006 Jan;16(1):97-118. doi: 10.1177/1049732305284002.
6
Legal and ethical issues in genetic testing and counseling for susceptibility to breast, ovarian and colon cancer.乳腺癌、卵巢癌和结肠癌易感性基因检测与咨询中的法律和伦理问题。
CMAJ. 1996 Mar 15;154(6):813-8.
7
Hereditary breast-ovarian cancer: clinical findings and medical management.遗传性乳腺癌-卵巢癌:临床发现与医学管理
Plast Surg Nurs. 2007 Jul-Sep;27(3):124-7. doi: 10.1097/01.PSN.0000290280.48197.e7.
8
Clinical implications of genetic testing for inherited breast and ovarian cancer risk.遗传性乳腺癌和卵巢癌风险基因检测的临床意义
Nurs Spectr (Wash D C). 1998 Nov 16;8(23):12-4.
9
Genetic risk assessment for breast and ovarian cancer.乳腺癌和卵巢癌的遗传风险评估
Adv Nurse Pract. 2003 Oct;11(10):40-8.
10
[Recommendations for treatment of individuals at risk for hereditary breast and ovarian carcinoma].[遗传性乳腺癌和卵巢癌高危个体的治疗建议]
Srp Arh Celok Lek. 2003 Jul-Aug;131(7-8):345-50.

引用本文的文献

1
Opioid therapy pharmacogenomics for noncancer pain: efficacy, adverse events, and costs.非癌性疼痛的阿片类药物治疗药物基因组学:疗效、不良事件及成本
Pain Res Treat. 2013;2013:943014. doi: 10.1155/2013/943014. Epub 2013 Sep 18.
2
Factors influencing intrafamilial communication of hereditary breast and ovarian cancer genetic information.影响遗传性乳腺癌和卵巢癌遗传信息家庭内部交流的因素。
Eur J Hum Genet. 2009 Jul;17(7):872-80. doi: 10.1038/ejhg.2009.33. Epub 2009 Mar 25.
3
Cancer genetic counselees' self-reported psychological distress, changes in life, and adherence to recommended surveillance programs 3-7 years post counseling.
癌症遗传咨询对象在咨询后3至7年自我报告的心理困扰、生活变化以及对推荐监测项目的依从性。
J Genet Couns. 2009 Apr;18(2):185-94. doi: 10.1007/s10897-008-9203-y. Epub 2009 Feb 11.
4
Results of an intervention for individuals and families with BRCA mutations: a model for providing medical updates and psychosocial support following genetic testing.针对携带BRCA突变的个人和家庭的干预结果:一种在基因检测后提供医学进展信息和心理社会支持的模式。
J Genet Couns. 2007 Aug;16(4):433-56. doi: 10.1007/s10897-006-9078-8. Epub 2007 Jun 27.
5
Men's decision-making about predictive BRCA1/2 testing: the role of family.男性关于BRCA1/2预测性检测的决策:家庭的作用。
J Genet Couns. 2005 Jun;14(3):207-17. doi: 10.1007/s10897-005-0384-3.